Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The combination of dasatinib and quercetin (DQ) has completed phase 1 clinical trials for Alzheimers disease, and navitoclax is currently in phase 3 clinical trials for myelofibrosis 29,30
Vitamin B12 shots are generally safe, with minimal side effects such as mild soreness at the injection site
Dihexa has also been patented for potential use in treating Alzheimers and Parkinsons disease, though human clinical evidence remains in early stages
Western blot analysis of thoracic aorta proteins showed that the classic aging markers P21 and P16 were significantly downregulated following FOXO4-DRI treatment, whereas the expression levels of the cell proliferation marker Ki-67 and Lamin B, a key protein involved in nuclear structural stability, were markedly upregulated (Figure 1A)
